ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

Randomized Trial Finds Sunscreen Use Cuts Risk Of Developing Melanoma

December 31, 2010

Cooperative Groups Start To Deploy Medidata Rave, Despite Contract Dispute

April 22, 2011

Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split

April 5, 1991

NCAB Okays Concepts For ICI Contract Support, Databases

October 11, 1991